AAP 2011: ADHD Guidelines Updated for Diagnosis and Treatment in Children [Video]

Article

Mark Wolraich, MD, FAAP, lead author, discussed the updated ADHD guidelines which now include information on the diagnosis and treatment of children and adolescents.

Mark Wolraich, MD, FAAP, lead author, discussed the updated ADHD guidelines which now include information on the diagnosis and treatment of children and adolescents.

"The biggest change in the guidelines is that previously we really only felt comfortable that we had high enough level of evidence to make recommendations in children 6-12 year of age because that's where the bulk of the research on ADHD has been done."

"We also felt that we could expand the age into adolescent. It is not that we didn't think that pre-school students and adolescents in the previous guideline existed. It was just that we didn't feel that we had enough evidence to make recommendations," said Wolraich.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.